Photocure ASA (0IMT.L)
NOK 60.8
(7.99%)
NOK 60.8
(7.99%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.04 NOK | 100.37% |
| 2022 | -2.66 NOK | -131.3% |
| 2021 | -1.15 NOK | -26.37% |
| 2020 | -0.91 NOK | -162.33% |
| 2019 | 1.46 NOK | 185.88% |
| 2018 | -1.70 NOK | -5.59% |
| 2017 | -1.61 NOK | -198.17% |
| 2016 | 1.64 NOK | 197.04% |
| 2015 | -1.69 NOK | -45.69% |
| 2014 | -1.16 NOK | 58.27% |
| 2013 | -2.78 NOK | -23.56% |
| 2012 | -2.25 NOK | -542.86% |
| 2011 | -0.35 NOK | -141.67% |
| 2010 | 0.84 NOK | -94.07% |
| 2009 | 14.16 NOK | 586.6% |
| 2008 | -2.91 NOK | 14.41% |
| 2007 | -3.40 NOK | -185.43% |
| 2006 | 3.98 NOK | 283.41% |
| 2005 | -2.17 NOK | 15.23% |
| 2004 | -2.56 NOK | -4.92% |
| 2003 | -2.44 NOK | 55.72% |
| 2002 | -5.51 NOK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.46 NOK | 255.17% |
| 2024 Q1 | -0.29 NOK | -163.04% |
| 2023 Q3 | -0.18 NOK | -212.5% |
| 2023 Q4 | 0.46 NOK | 355.56% |
| 2023 Q2 | 0.16 NOK | 137.21% |
| 2023 Q1 | -0.43 NOK | 45.57% |
| 2023 FY | - NOK | 100.37% |
| 2022 Q4 | -0.79 NOK | -113.51% |
| 2022 Q3 | -0.37 NOK | 45.59% |
| 2022 Q2 | -0.68 NOK | 17.07% |
| 2022 Q1 | -0.82 NOK | 21.9% |
| 2022 FY | - NOK | -131.3% |
| 2021 Q3 | -0.27 NOK | 32.5% |
| 2021 FY | - NOK | -26.37% |
| 2021 Q2 | -0.40 NOK | -170.18% |
| 2021 Q1 | 0.57 NOK | 50.0% |
| 2021 Q4 | -1.05 NOK | -288.89% |
| 2020 Q3 | -0.23 NOK | 37.84% |
| 2020 Q2 | -0.37 NOK | 54.32% |
| 2020 Q1 | -0.81 NOK | -151.27% |
| 2020 FY | - NOK | -162.33% |
| 2020 Q4 | 0.38 NOK | 265.22% |
| 2019 Q2 | -0.24 NOK | -4.35% |
| 2019 Q4 | 1.58 NOK | 5366.67% |
| 2019 Q1 | -0.23 NOK | 47.73% |
| 2019 FY | - NOK | 185.88% |
| 2019 Q3 | -0.03 NOK | 87.5% |
| 2018 Q2 | -0.79 NOK | -464.29% |
| 2018 Q4 | -0.44 NOK | -100.0% |
| 2018 FY | - NOK | -5.59% |
| 2018 Q1 | -0.14 NOK | 70.83% |
| 2018 Q3 | -0.22 NOK | 72.15% |
| 2017 Q1 | -0.32 NOK | -148.48% |
| 2017 FY | - NOK | -198.17% |
| 2017 Q4 | -0.48 NOK | -2.13% |
| 2017 Q3 | -0.47 NOK | -113.64% |
| 2017 Q2 | -0.22 NOK | 31.25% |
| 2016 Q1 | -0.03 NOK | 91.43% |
| 2016 FY | - NOK | 197.04% |
| 2016 Q4 | 0.66 NOK | 25284.62% |
| 2016 Q3 | 0.00 NOK | -99.69% |
| 2016 Q2 | 0.84 NOK | 2900.0% |
| 2015 Q4 | -0.35 NOK | -52.17% |
| 2015 Q3 | -0.23 NOK | 54.9% |
| 2015 Q2 | -0.51 NOK | 0.0% |
| 2015 Q1 | -0.51 NOK | 56.78% |
| 2015 FY | - NOK | -45.69% |
| 2014 Q2 | -0.20 NOK | 67.21% |
| 2014 Q3 | 1.13 NOK | 665.0% |
| 2014 Q4 | -1.18 NOK | -204.42% |
| 2014 FY | - NOK | 58.27% |
| 2014 Q1 | -0.61 NOK | -79.41% |
| 2013 Q3 | -0.62 NOK | 13.89% |
| 2013 Q4 | -0.34 NOK | 45.16% |
| 2013 Q2 | -0.72 NOK | 28.71% |
| 2013 Q1 | -1.01 NOK | -941.67% |
| 2013 FY | - NOK | -23.56% |
| 2012 Q1 | -0.55 NOK | -144.0% |
| 2012 FY | - NOK | -542.86% |
| 2012 Q3 | -1.21 NOK | -86.15% |
| 2012 Q2 | -0.65 NOK | -18.18% |
| 2012 Q4 | 0.12 NOK | 109.92% |
| 2011 Q3 | -0.32 NOK | 63.22% |
| 2011 Q1 | -0.75 NOK | -20.97% |
| 2011 Q2 | -0.87 NOK | -16.0% |
| 2011 Q4 | 1.25 NOK | 490.63% |
| 2011 FY | - NOK | -141.67% |
| 2010 Q4 | -0.62 NOK | -16.98% |
| 2010 Q2 | 2.76 NOK | 531.25% |
| 2010 Q3 | -0.53 NOK | -119.2% |
| 2010 FY | - NOK | -94.07% |
| 2010 Q1 | -0.64 NOK | 22.89% |
| 2009 Q2 | -0.31 NOK | 58.11% |
| 2009 Q4 | -0.83 NOK | -105.16% |
| 2009 FY | - NOK | 586.6% |
| 2009 Q1 | -0.74 NOK | 0.0% |
| 2009 Q3 | 16.08 NOK | 5287.1% |
| 2008 FY | - NOK | 14.41% |
| 2007 FY | - NOK | -185.43% |
| 2006 FY | - NOK | 283.41% |
| 2005 FY | - NOK | 15.23% |
| 2004 FY | - NOK | -4.92% |
| 2003 FY | - NOK | 55.72% |
| 2002 FY | - NOK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| BerGenBio ASA | -13.30 NOK | 100.271% |